Immunocore Holdings plc Increase Decrease In Number Of Ordinary Shares Issued
Immunocore Holdings plc (IMCR) reported Increase Decrease In Number Of Ordinary Shares Issued of 34.26 thousand shares for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-25.
Discontinued › Notes › Shares
ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued · last filed 2021-03-25
| Period end | Increase Decrease In Number Of Ordinary Shares Issued 12 month |
|---|---|
| 2020-12-31 | 34.26K shares 20-F · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |